FDA.reportPublic FDA data

avatrombopag 10 MG Oral Granules

RxCUI
2721188
RxNorm name
avatrombopag 10 MG Oral Granules
Display name
avatrombopag 10 MG Oral Granules
Full name
avatrombopag 10 MG Oral Granules
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Doptelet SprinkleAVATROMBOPAGAkaRx, Inc.e2d5960d-6c18-46cc-86bd-089222b098522025-08-13Warnings, Adverse reactionsExact identifier
rxcui: 2721188

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e2d5960d-6c18-46cc-86bd-089222b09852avatrombopag 10 MG Oral Granules [PSN] · avatrombopag 10 MG Oral Granules [SCD] · avatrombopag 10 MG (equivalent to avatrombopag maleate 11.787 MG) Oral Granules [SY]321These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET. DOPTELET ® (avatrombopag ) tablets, for oral use DOPTELET® SPRINKLE (avatrombopag) oral granules Initial U.S. Approval: 201820250813